RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
GALLAMINI A
Collezione AO Cuneo
Items : 49
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):415-423. doi: 10.1002/hon.3117. Epub 2023 Jan 4.
2023
AO Cuneo
Rambaldi A; Gallamini A; Trentin L; La Nasa G; Sorasio R; Viviani S; Schiavotto C; Romano A; Pavoni C; Patti C; Picardi M; Gregianin M; Chiaravalloti A; Schillaci O; Bergesio F; Menga M; Bianchi A; Chauvie S; Fallanca F; Guerra L; Biggi A;
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi. in Annals of hematology / Ann Hematol. 2021 Oct;100(10):2547-2556. doi: 10.1007/s00277-021-04604-x. Epub 2021 Jul 30.
2021
AO Cuneo
Ciammella P; Ghiggi C; Gallamini A; Sorasio R; Balzarotti M; Giordano L; Chimienti E; Rodari M; Liberati AM; Fabbri A; Ricci F; Bonfichi M; Kovalchuk S; Pulsoni A; Musso M; Palombi F; Consoli U; Carella M; Specchia G; Califano C; Spina M; Mazza R; Santoro A; Ricardi U; Chauvie S; Carlo-Stella C; Merli F;
Standardization of (18)F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Jan 10;39(2):116-125. doi: 10.1200/JCO.20.00386. Epub 2020 Nov 5.
2021
AO Cuneo
Kraeber-Bodéré F; Bodet-Milin C; Cavo M; Fanti S; Perrot A; Gay F; Sonneveld P; Karlin L; Barbato S; Garderet L; Boccadoro M; Macro M; Patriarca F; Caillot D; Gallamini A; Gamberi B; Chauvie S; Tacchetti P; Versari A; Bailly C; Nanni C; Carlier T; Dozza L; Zamagni E; Moreau P;
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma. in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... / Q J Nucl Med Mol Imaging. 2021 Dec;65(4):410-415. doi: 10.23736/S1824-4785.17.02993-4. Epub 2017 Jul
2021
AO Cuneo
Gallamini A; Meignan M; Gregianin M; Hutchings M; Fallanca F; Menga M; Chauvie S; Bianchi A; Bergesio F; Biggi A;
Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study. in Biomedicines / Biomedicines. 2021 Aug 6;9(8):971. doi: 10.3390/biomedicines9080971.
2021
AO Cuneo
Gallamini A; Sambuceti G; Piana M; Chauvie S; Morbelli S; Schenone D; Cossu V; Campi C; Miceli A; Donegani MI; Lai R; Borra A; Bauckneht M; Marini C;
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):501-508. doi: 10.1002/hon.2775. Epub 2020 Jul 30.
2020
AO Ordine Mauriziano
AO Cuneo
Gallamini A; Gianni AM; Corradini P; Galbiati M; Ferreri AJM; Farina L; Zanotti R; Cimminiello M; Tarella C; Gottardi D; Guidetti A; Sorasio R; Trentin L; Romano A; Patti C; Rossi A; Taverna F; Pavoni C; Mazzocchi A; Viviani S; Rambaldi A;
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Nov 20;38(33):3905-3913. doi: 10.1200/JCO.20.00935. Epub 2020 Sep 18.
2020
AO Cuneo
Rambaldi A; Tarella C; Guerra L; Fallanca F; Ficola U; Mulé A; Viero P; Schiavotto C; Cimminiello M; Pavoni C; Zanotti R; Sorasio R; Battistini R; Chauvie S; Gini G; Trentin L; Bolis S; Oppi S; Viviani S; Cantonetti M; Romano A; Picardi M; Patti C; Gallamini A; Rossi A;
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial. in Cancer medicine / Cancer Med. 2020 Dec;9(23):8735-8746. doi: 10.1002/cam4.3396. Epub 2020 Nov 6.
2020
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
Gallamini A; Rambaldi A; Massimo Gianni A; Chauvie S; Biggi A; Ferreri AJM; Viero P; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Zoli V; Gavarotti P; Bolis S; Trentin L; La Nasa G; Cantonetti M; Picardi M; Rossi A; Patti C; Viviani S; Tarella C; Di Raimondo F; Pavoni C; Romano A;
The role of PET/CT in the modern treatment of Hodgkin lymphoma. in Cancer treatment reviews / Cancer Treat Rev. 2019 Jul;77:44-56. doi: 10.1016/j.ctrv.2019.06.002. Epub 2019 Jun 19.
2019
AO Cuneo
Gallamini A; Zaucha R; Biggii A; Zaucha JM; Chauvie S;
Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing. in Bone marrow transplantation / Bone Marrow Transplant. 2019 Jan;54(1):159-163. doi: 10.1038/s41409-018-0268-4. Epub 2018 Aug 16.
2019
AO Cuneo
Visani G; Malagola M; Gazzola A; Rapezzi D; Piccaluga PP; Gallamini A;
Dual-point FDG-PET/CT for treatment response assessment in Hodgkin lymphoma, when an FDG-avid lesion persists after treatment. in American journal of nuclear medicine and molecular imaging / Am J Nucl Med Mol Imaging. 2019 Jun 15;9(3):176-184. eCollection 2019.
2019
AO Cuneo
Gallamini A; Darcourt J; Thyss A; Biggi A; Malkowski B; Taszner M; Zaucha JM; Chauvie S; Bergesio F; Bianchi A; Zwarthoed C; Morbelli S; Borra A;
2019
AO Cuneo
Zamagni E; Nanni C; Dozza L; Carlier T; Tacchetti P; Versari A; Chauvie S; Gallamini A; Attal M; Gamberi B; Caillot D; Patriarca F; MacRo M; Boccadoro M; Garderet L; Fanti S; Perrot A; Gay F; Sonneveld P; Karlin L; Bodet-Milin C; Moreau P; Kraeber-Bodéré F; Cavo M;
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21
2018
AO Cuneo
AOU Città della Salute di Torino
Zamagni E; Cavo M; Gamberi B; Ghedini P; Gay F; Patriarca F; Gallamini A; Rensi M; Bellò M; Chauvie S; Bertone E; Bianchi A; Nanni C; Versari A; Fanti S;
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma? in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1463-1464. doi: 10.1007/s00259-018-4005-4. Epub 2018 Apr
2018
AO Cuneo
Gallamini A; Meignan M; Clerc J; Chauvie S; Casasnovas O; Versari A; Kanoun S; Cottereau AS; Buvat I;
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Gottardi D; Battistini R; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...
A Score-Based Approach to (18)F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2017 Oct 26;7(4):57. doi: 10.3390/diagnostics7040057.
2017
AO Cuneo
Sambuceti G; Marini C; Bruzzi P; Gallamini A; Massaia M; Bellodi A; Arboscello E; Canepari ME; Spallarossa P; Sarocchi M; Nieri A; Piva R; Ferrarazzo G; Fiz F; Morbelli S; Bauckneht M;
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3051-3057. doi: 10.1093/annonc/mdx524.
2017
AO Cuneo
Walewski J; Gallamini A; Knopinska-Posluszny W; Swietlik D; Wróbel T; Zaucha R; Lesniewski-Kmak K; Giza A; Chamier-Cieminska A; Kurczab P; Romanowicz A; Bergesio F; Rybka J; Kroll-Balcerzak R; Woszczyk D; Dziuk M; Kobylecka M; Fallanca F; Biggi A; Fijolek-Warszewska A; Kulikowski W; Tajer J; Chauvie S; Subocz E; Malkowski B; Zaucha JM;
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study. in The Lancet. Haematology / Lancet Haematol. 2016 Oct;3(10):e467-e479. doi: 10.1016/S2352-3026(16)30108-9.
2016
AO Cuneo
AOU Città della Salute di Torino
Pileri SA; d'Amore F; Zinzani PL; Gascoyne RD; Broccoli A; Argnani L; Steidl C; Subocz E; Rybka J; Tajer J; Kulikowski W; Zaucha JM; Hamilton-Dutoit S; Kamper P; Piccaluga PP; Borra A; Stelitano C; Trentin L; Patti C; Romano A; Levis A; Merli F; Vitolo U; Rigacci L; Biggi A; Sista MT; Fanti S; Fuligni F; Agati P; et alii...
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma). in Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) / Phys Med. 2016 May;32(5):651-6. doi: 10.1016/j.ejmp.2016.04.004. Epub 2016 Apr 28.
2016
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
Gallamini A; Federico M; Vitolo U; Rigacci L; Martelli M; Balzarotti M; Luminari S; Cabras MG; Musto P; Storto G; Guerra L; Versari A; Brambilla M; Biggi A; Fioroni F; Bergesio F; Chauvie S;
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma. in Journal of hematology & oncology / J Hematol Oncol. 2016 Mar 16;9:26. doi: 10.1186/s13045-016-0255-4.
2016
AO Cuneo
Gallamini A; Di Raimondo F; Romano A; Martino M; Porcella R; Lai S; Caria R; Celeghini I; Oppi S; Littera R; Greco M; La Nasa G; Carcassi C; Caocci G;
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.
2016
AO Cuneo
AOU Città della Salute di Torino
Fanti S; Cavo M; Gamberi B; Gay F; Patriarca F; Gallamini A; Rambaldi I; Bellò M; Rensi M; Bianchi A; Chauvie S; Versari A; Zamagni E; Nanni C;
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia. in Haematologica / Haematologica. 2015 Jun;100(6):786-93. doi: 10.3324/haematol.2014.123273. Epub 2015 Mar 6.
2015
AO Cuneo
AOU Città della Salute di Torino
Rambaldi A; Marfisi RM; Oldani E; Gallamini A; Cortelazzo S; Fumagalli M; Marmont F; Borlenghi E; Parolini M; Tosi M; Spinelli O; Scattolin AM; Corti C; Cortelezzi A; Romani C; Mattei D; Cassibba V; Rossi G; Pogliani EM; Audisio E; Intermesoli T; Masciulli A; Bassan R;
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). in American journal of hematology / Am J Hematol. 2015 Jun;90(6):499-503. doi: 10.1002/ajh.23994. Epub 2015 May 10.
2015
AO Cuneo
AOU Città della Salute di Torino
Bosi A; Gotti M; Rosaria S; Maria SP; Levis A; Stefoni V; Vitolo U; Spina M; Stelitano C; Balzarotti M; Castagnoli A; Merli F; Zinzani PL; Biggi A; Rigacci L; Puccini B; Gallamini A;
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. in Leukemia / Leukemia. 2015 Jun;29(6):1360-5. doi: 10.1038/leu.2015.21. Epub 2015 Feb 4.
2015
AO Cuneo
Riminucci M; Nicolai E; Trastulli F; Campanelli M; Autore F; Laurenti L; Rossi D; Sacchetti GM; Bellò M; Coscia M; Morabito F; Gentile M; Rago A; Cimino G; Biggi A; Paoloni F; Chauvie S; Mauro FR; Gaidano G; Guarini A; Gallamini A; Foà R;
Positron Emission Tomography (PET) in Oncology. in Cancers / Cancers (Basel). 2014 Sep 29;6(4):1821-89. doi: 10.3390/cancers6041821.
2014
AO Cuneo
Gallamini A; Zwarthoed C; Borra A;
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma. in Leukemia / Leukemia. 2014 Sep;28(9):1885-91. doi: 10.1038/leu.2014.79. Epub 2014 Feb 20.
2014
AO Ordine Mauriziano
AO Cuneo
AOU Alessandria
Pileri S; Dodero A; Tarella C; Ferreri A; Patti C; Baldini L; Bruno B; Salvi F; Todeschini G; Rossi G; Benedetti F; Olivieri A; Gallamini A; Patriarca F; Miceli R; Rambaldi A; Corradini P; Vitolo U;
Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27.
2014
AO Cuneo
Massaia M; Morra E; Nichelatti M; De Paoli L; Rossi D; Frustaci AM; Gallamini A; Motta M; Ghia P; Cascavilla N; Orlandi E; Petrizzi VB; Coscia M; Gaidano G; Tedeschi A; Montillo M;
Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2014 May;20(5):717-23. doi: 10.1016/j.bbmt.2014.02.002. Epub 2014 Feb
2014
AO Cuneo
Gallamini A; Ghiglia A; Borra A; Celeghini I; Fiore F; Mordini N; Mattei D; Castellino C; Di Marco C; Marenchino D; Rapezzi D; Strola G; Grasso M; Bonferroni M; Sorasio R;
WIDEN: A tool for medical image management in multicenter clinical trials. in Clinical trials (London, England) / Clin Trials. 2014 Jun;11(3):355-361. doi: 10.1177/1740774514525690.
2014
AO Cuneo
Gallamini A; Schillaci O; Chiaravalloti A; Guerra UP; Gregianin M; Ficola U; Fallanca F; Cavallo A; Cerello P; Stancu A; Biggi A; Chauvie S;
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. in Haematologica / Haematologica. 2014 Jun;99(6):1107-13. doi: 10.3324/haematol.2013.103218. Epub 2014 Mar 21.
2014
AO Cuneo
Gallamini A; Barrington SF; Hutchings M; Luminari S; Salvi F; Viviani S; Bolis S; Rusconi C; Brice P; Dann EJ; Trentin L; Casasnovas O; Pulsoni A; Coleman M; Hofman MS; Rigacci L; Seymour JF; Zaucha JM; Loft A; Mikhaeel GN; Biggi A; Meignan M; Kostakoglu L; Gregianin M; Chauvie S;
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Dec;25(12):2339-2350. doi: 10.1093/annonc/mdu152. Epub 2014 Apr 9.
2014
AO Cuneo
ASL Asti
Pimpinelli N; Pileri S; Gallamini A; Billio A; Barosi G; Marchetti M; Corradini P; Rossi G; Zinzani PL; Tura S;
Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CT. in Medicine / Medicine (Baltimore). 2014 Aug;93(8):e50. doi: 10.1097/MD.0000000000000050.
2014
AO Cuneo
Simonetti G; Schillaci O; Guazzaroni M; Orlacchio A; Cantonetti M; Gallamini A; Danieli R; Caracciolo CR; Travascio L; Chiaravalloti A;
Phase 3 study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL): Echelon-1 study in Journal of Clinical Oncology
2014
AO Cuneo
Ansell SM; Younes A; Connors JM; Gallamini A; Kim WS; Friedberg JW; Feldman TA; Collins G; Bartlett N; Wang J; Brady K; Sachs J; Huebner D; Hunder NNH; Radford J;
International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. in Journal of nuclear medicine : official publication, Society of Nuclear Medicine / J Nucl Med. 2013 May;54(5):683-90. doi: 10.2967/jnumed.112.110890. Epub 2013 Mar 20.
2013
AO Cuneo
Barrington SF; Hofman MS; Malkowski B; Meignan M; Gregianin M; Kostakoglu L; Hutchings M; Chauvie S; Biggi A; Gallamini A;
2013
AO Cuneo
Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F;
Upstaging by pet-ascertained bone and bone marrow involvement in hodgkin lymphoma-definitions matter in Haematologica
2013
AO Cuneo
Borra A; El-Galaly TC; Zaucha JM; Rigacci L; Rapezzi D; Rago A; Bolis S; Gavarotti P; Rusconi C; Trentin L; Stelitano C; Biggi A; Gormsen LC; D'Amore F; Hutchings M; Gallamini A;
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials? in Blood / Blood. 2012 Dec 13;120(25):4913-20. doi: 10.1182/blood-2012-03-403790. Epub 2012 Aug 28.
2012
AO Cuneo
Gallamini A; Kostakoglu L;
Dual-point FDG-PET: A novel scanning technique in Hodgkin lymphoma with bulky disease in Journal of Clinical Oncology
2012
AO Cuneo
Gallamini A; Bianchi A; Borra A; Zaucha MJ; Malkowski B; Thyss A; Mounier N; Micheline R-C; Darcourt J; Zwarthoed C; Chauvie S; Biggi A;
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. in British journal of haematology / Br J Haematol. 2011 Mar;152(5):551-60. doi: 10.1111/j.1365-2141.2010.08485.x. Epub 2010 Dec 20.
2011
AO Cuneo
Gianni AM; Chauvie S; Ficola U; Fallanca F; Barrington S; Biggi A; Rambaldi A; Leone M; Mulè A; Sorasio R; Gavarotti P; Feldman T; Stelitano C; Cantonetti M; Di Raimondo F; Fiore F; Rossi A; Viviani S; Gallamini A; Patti C;
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Mar;22(3):671-680. doi: 10.1093/annonc/mdq403. Epub 2010 Aug 6.
2011
AO Cuneo
Gallamini A; Pane F; Nicolai E; Grimaldi F; Soricelli A; Picardi M;
Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010. in Leukemia & lymphoma / Leuk Lymphoma. 2011 Apr;52(4):583-6. doi: 10.3109/10428194.2010.551162.
2011
AO Cuneo
Gallamini A; O'Doherty M;
2010
ASL Asti
ASL Torino 4
AO Cuneo
Levis A; Gioia DM; Godio L; Girotto M; Allione B; Bertassello C; Bonferroni M; Ciriello MM; Cametti G; Ciravegna G; Ferranti A; Lunghi M; Ferrero D; Freilone R; Gatto S; Salvi F; Savio M; Scaravaglio P; Stacchini A; Tonso A; Boccadoro M; Gaidano G; Gallamini A; Vitolo U; Saglio G;
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. in Leukemia & lymphoma / Leuk Lymphoma. 2009 Nov;50(11):1761-4. doi: 10.3109/10428190903308072.
2009
AO Cuneo
Gallamini A; Meignan M; Sorasio R; Fiore F;
Early interim PET scan in Hodgkin lymphoma: where do we stand? in Leukemia & lymphoma / Leuk Lymphoma. 2008 Apr;49(4):659-62. doi: 10.1080/10428190801888704.
2008
AO Cuneo
Gallamini A; Polliack A; Hutchings M; Avigdor A;
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2007 Aug 20;25(24):3746-52. doi: 10.1200/JCO.2007.11.6525. Epub 2007 Jul 23.
2007
AO Cuneo
Biggi A; Vitolo U; Stelitano C; D'Amore F; Di Raimondo F; Loft A; Patti C; Hansen M; Merli F; Specht L; Rigacci L; Hutchings M; Gallamini A; Sancetta R; Trentin L; Luminari S; Iannitto E; Viviani S; Pierri I; Levis A;
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. in Haematologica / Haematologica. 2006 Apr;91(4):475-81.
2006
AO Cuneo
Levis A; Torchio P; Gregianin M; Pelosi E; Versari A; Castagnoli A; Biggi A; Tavera S; Stelitano C; Trentin L; Iannitto E; Sancetta R; Vitolo U; Luminari S; Capodanno I; Bosi A; Nassi L; Merli F; Gallamini A; Rigacci L;
NK/T-cell lymphomas 'nasal type': An Italian multicentric retrospective survey in Annals of Oncology
2006
AO Cuneo
Pagano L; Gallamini A; Trapè G; Fianchi L; Mattei D; Todeschini G; Spadea A; Cinieri S; Iannitto E; Martelli M; Nosari A; Di Bona E; Tosti ME; Petti MC; Falcucci P; Montanaro M; Pulsoni A; Larocca LM; Leone G;
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. in Blood / Blood. 2004 Apr 1;103(7):2474-9. doi: 10.1182/blood-2003-09-3080. Epub 2003 Nov 26.
2004
AO Cuneo
Brugiatelli M; Federico M; Santini G; Todeschini G; Devizzi L; Rigacci L; Cortelazzo S; Zaja F; Iannitto E; Brusamolino E; Martelli M; Gallamini A; Morabito F; Vitolo U; Mattei D; Bellei M; Stelitano C; Calvi R;
[Pleural effusion in a case of non-Hodgkin's lymphoma: diagnostic use of molecular analysis]. in Recenti progressi in medicina / Recenti Prog Med. 1990 Sep;81(9):568-70.
1990
AO Cuneo
Bonferroni M; Cavallero GB; di Celle PF; Gallamini A; Foà R;